Through the SD Tech Fund™, SDTC supports technologies that address the challenges of Clean Air, Soil, Water and Climate Change, including technology solutions focused on these current technology priority areas:

• Responsible resource development: Mitigate environmental impacts associated with Canada’s natural resource sector through technologies in the oil and gas, mining, and forestry sectors.

• Resource and energy efficiency: Technologies that encourage energy efficiency in buildings and industrial processes, with a focus on industrial water use efficiency.

• Clean energy: Technologies that enable clean energy production, distributed power generation and energy storage as well as technologies related to carbon capture and storage, integrated energy systems, and biorefinery/biochemical production.

• Northern and remote communities: Innovative technologies and solutions for self-sufficiency in smaller communities, such as food security, heavy-lift transportation, small-scale renewable energy and microgrid applications.

• Next generation transportation: Technologies related to next generation vehicles having reduced emissions and higher energy efficiency, with a focus on freight transportation.

• Agriculture: Technologies that increase yield and improve temperature and drought resistance of agricultural crops, mitigate land-use changes and biodiversity loss and diversify farm incomes.

The SD Natural Gas Fund™, a collaboration with the Canadian Gas Association, focuses on the following priority areas. 

• Residential (small-scale affordable CHP units, ultra-efficient water heaters, technologies that improve the efficiency of residential heating and/or cooling).

• Commercial (technologies that improve the efficiency of heating systems, measurement and data management to better control natural gas consumption, natural gas cooling systems).

• Industrial (higher-efficiency industrial heating equipment, CO2 capture systems, less energy-intensive hydrogen production).

• Power generation (higher efficiency power generation, emissions control technologies, natural gas storage solutions for remote locations).

• Transportation (more efficient and lower emission natural gas engines, alternative natural gas engines, lower-cost solutions).

• Renewable natural gas (technologies that improve cleanup economics, cost-effective small-scale anaerobic digesters).

The prevalence of neurodegenerative diseases of aging is high and growing rapidly. This Program aims to support innovative ideas that can advance the development of scientific breakthroughs to accelerate the creation of safe, effective treatments for these diseases. The Program will support world-class projects with excellent preliminary data and significant potential to accelerate the development of therapeutics to treat one or more neurodegenerative diseases of aging.

Letter of intent due March 3, 2015

The purpose of this program is to fund research at Ontario colleges and universities to encourage applied research in transportation infrastructure in Ontario. This program is intended to solicit innovative solutions to assist the Ministry in meeting its strategic plan and to encourage undergraduate and graduate research in transportation and infrastructure engineering by providing funding to aid in such research.

Associated Documents

• HIIFP 2015 Guidelines
• HIIFP 2015 Attachment B - Application Form
• HIIFP 2015 Attachment C - Research Proposal Summary
• HIIFP 2015 Attachment D - Budget Summary
• HIIFP 2015 Attachment E - Progress Report Template
• HIIFP 2015 Attachment F - Technical Style Manual

The aim of the call is to facilitate multinational, collaborative research projects that will address important questions relating to the neurodevelopmental nature of neurological and psychiatric disorders. The call will accept proposals ranging from understanding basic mechanisms of disease through proof-of-concept clinical studies in humans. These may include - without excluding others - diseases such as autism, schizophrenia, mental retardation, attention deficit disorders, foetal alcohol syndrome, epilepsy syndromes, cerebral palsy, inherited peripheral neuropathies, sensory disorders and spastic paraplegias. Disorders that manifest only with neurodegenerative features during adulthood will not be eligible for this call.

Pre-Proposal due March 9, 2015.

The goal of the Late Life Issues Initiative is to help build knowledge and capacity in this field of research, create high-quality evidence to inform health care professionals, and policy-makers. The Late Life Issues teams will ensure that Canada emerges as a leader in this area, creating evidence in areas where there is currently limited research evidence.

The objective of this funding opportunity is to support research aimed at offering relevant evidence for late-life issues from the perspective of patients, their families and caregivers, health professionals, the healthcare system, and society, and that will take into account policy, legal and ethical aspects.

It is expected that the successful teams will generate new knowledge, bridge gaps between research outcomes and impact on health, and enhance the capacity for knowledge transfer in the area of Late Life Issues by addressing the following research areas:

• Developing patient-centered care approaches, tools, and empowerment for older adults in late-life, and their caregivers;
• Developing multi-disciplinary and inter-professional approaches to optimize care and resources, while recognizing issues around multiple co-morbidities, transforming and building upon existing knowledge on issues in the geriatrics field;
• Promoting novel research and interventions to optimize the quality of life and wellness of the individual in late-life, as well as their caregivers, in recognition that late-life issues are part of the trajectory of aging and not limited to end of life issues;
• Evaluating and building upon existing care models for individuals in late-life including, and innovative research on outcome measures;
• Addressing the challenges in managing multi-morbidity across the continuum of care (acute, rehabilitative, community and long-term care);
• Examining disparities in health service availability and utilization in later life among marginalized groups (e.g. older persons living in rural and remote areas, Aboriginal elderly, immigrant elderly; lesbian, gay, bisexual and transgender (LGBT) elderly).

The specific objective of this funding opportunity is to facilitate multinational, collaborative research projects that will address important questions regarding ethical, philosophical, legal and socio-cultural aspects related to neuroscientific research and recent advances in the field.

Subjects under this general heading include but are not limited to:

1. the consequences of the development of neuroscientific diagnostic methods (e.g., handling of incidental findings; the "right not to know"; very early disease prediction before symptoms occur; diagnosis in absence of treatment options; interactions between socio-culturally diverse patients and health personnel; availability of novel expensive methods)
2. abnormal behaviour reduced to deviant brain states (e.g., expansion of the concept of illness; seeing psychiatric symptoms merely as specific neurochemical imbalances) use of brain data and brain interventions in legal contexts (e.g., "brain reading" for the detection of deception; brain intervention of offenders; psychosurgery; insurance law)
3. neuroenhancement such as alteration of mental states (cognitive, affective) and abilities (e.g., cognition, sleep, appetite, sexual behaviour) in healthy subjects by pharmacological or by electrical/magnetic brain stimulation
4. intelligent technologies and close human-machine interactions (e.g., Ambient Assisted Living, Brain-Computer Interfaces)
5. personality changes as side effects of neurological or psychiatric therapies (e.g., Deep Brain Stimulation; brain implants)
6. the impact of modern neuroscience on traditional philosophical questions, concepts and theories regarding fundamental aspects of human nature (e.g., the relationship between mind and brain, the nature of consciousness, self- and personal identity, free will)
7. bio-banking of neural tissue (e.g., tissue donation, deceased donor tissues, data protection, possible consequences for relatives)
8. clinical research with patients suffering from neurological or psychiatric diseases (e.g., developing tools to improve the assessment of decision-making capacity of the patients, analysis of legal measures to protect those who do not have the capacity to consent)
9. societal and cultural changes induced by neuroscientific knowledge and its application.

Pre-Proposal due March 9, 2015.

he "Joint Canada-Israel Health Research Program" (the Initiative) seeks to support fundamental research at the cutting-edge of biomedical science with a primary focus on brain research. This first call for proposals is directed toward new frontiers in neuroscience and subsequent calls may extend to other organs and diseases, and other topics in health sciences.

The organizations funding this Initiative support the search for breakthroughs in health sciences that have the potential to bring about enduring changes across the globe, including in developing regions.

The Initiative will support world-class research teams co-led by Canadian and Israeli investigators. The teams will be expected to integrate researchers from low and middle income countries to further their scientific capacity. In their capacity as collaborators or trainees, researchers from Eligible Countries will contribute to and benefit from their involvement in the Initiative.

Neurodegenerative diseases (ND) are debilitating and largely untreatable conditions that are strongly linked with age. In Europe, there are estimated to be between 6.3 and 7.3 million people suffering from Alzheimer’s disease and related disorders, the most frequent class of neurodegenerative diseases. This figure is expected to double every 20 years as the European population ages. The total direct and informal care costs of Alzheimer’s and related disorders are in the range of €105-160 billion per year across the European Union. Existing treatments for neurodegenerative diseases are limited in effect and mainly address the symptoms rather than the cause. In this context, the ‘Joint Programme Neurodegenerative Disease Research’ (JPND) has been established  in order to better coordinate European efforts on the level of transnational collaboration and project coordination on the basis of the joint European Research Strategy, published in February 2012.

With the aim to tackle the leading medical and societal challenges faced by our society, this joint transnational co-funded call (JTC) is launched in partnership with the European Commission (EC) under the ERA-NET Co-fund scheme. As a partner of JPND and under Horizon 2020, the European Commission (EC) is scaling up the implementation of the JPND research strategy by providing additional funding to ‘top up’ the funding that is being made available through national/regional funding organisations. The goal of the partners is to maximize the number of high quality transnational scientific projects that can be funded through this call. These projects must demonstrate clear scientific added value from working across national borders.

Scholarships for the Next Generation of Scientists is a Cancer Research Society funding program with the goal of supporting the future generation of Canadian researchers.The award consists of two parts covering a period of three years, with no possibility for renewal.